QuestionMay 29, 2025

Which calcitonin gene -related peptide antibody is most likely to result in facial flushing after administration? Erenumab Atogepant Eptinezumab Ubrogepant

Which calcitonin gene -related peptide antibody is most likely to result in facial flushing after administration? Erenumab Atogepant Eptinezumab Ubrogepant
Which calcitonin gene -related peptide antibody is most likely to
result in facial flushing after administration?
Erenumab
Atogepant
Eptinezumab
Ubrogepant

Solution
4.0(263 votes)

Answer

Erenumab Explanation 1. Identify the type of drugs Erenumab and Eptinezumab are CGRP monoclonal antibodies. Atogepant and Ubrogepant are CGRP receptor antagonists. 2. Determine side effects associated with CGRP antibodies Facial flushing is a known side effect associated with CGRP monoclonal antibodies, particularly Erenumab.

Explanation

1. Identify the type of drugs<br /> Erenumab and Eptinezumab are CGRP monoclonal antibodies. Atogepant and Ubrogepant are CGRP receptor antagonists.<br /><br />2. Determine side effects associated with CGRP antibodies<br /> Facial flushing is a known side effect associated with CGRP monoclonal antibodies, particularly Erenumab.
Click to rate:

Similar Questions